# Beta Blockers In Acute Ischemic Stroke

> **NCT01061190** · PHASE2,PHASE3 · COMPLETED · sponsor: **Wilhelm Haverkamp** · enrollment: 20 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Propranolol

## Key facts

- **NCT ID:** NCT01061190
- **Lead sponsor:** Wilhelm Haverkamp
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2011-10
- **Final completion:** 2013-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-10-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01061190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01061190, "Beta Blockers In Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01061190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*